An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer
Public ClinicalTrials.gov record NCT01677455. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT01677455
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Synta Pharmaceuticals Corp.
- Industry
- Enrollment
- 51 participants
Conditions and interventions
Conditions
Interventions
- ganetespib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2012
- Primary completion
- Mar 31, 2015
- Completion
- Jul 31, 2015
- Last update posted
- Nov 4, 2015
2012 – 2015
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Synta Pharmaceuticals Investigative Site | Birmingham | Alabama | 35249 | — |
| Synta Pharmaceuticals Investigative Site | Altanta | Georgia | 30341 | — |
| Synta Pharmaceuticals Investigative Site | Boston | Massachusetts | 02111 | — |
| Synta Pharmaceuticals Investigative Site | New York | New York | 10065 | — |
| Synta Pharmaceuticals Investigative Site | Durham | North Carolina | 27710 | — |
| Synta Pharmaceuticals Investigative Site | Columbus | Ohio | 43210 | — |
| Synta Pharmaceuticals Investigative Site | Philadelphia | Pennsylvania | 19111-2497 | — |
| Synta Pharmaceutical Investigative Site | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01677455, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 4, 2015 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01677455 live on ClinicalTrials.gov.